NFKB1 and hepatocellular carcinoma: Apigenin inhibited migration and metastasis of human hepatocellular carcinoma (HCC) cells by suppressing the NF‐κB/Snail pathway and reversing increases in epithelial–mesenchymal transition (EMT) marker levels (Qin et al., 2016).